Nadine M. Ritter

Latest from Nadine M. Ritter

20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
CMC Forums
20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series20 Years of Chemistry, Manufacturing, and Controls Strategy. A Conversation About the CASSS CMC Forum Series
byCheryl Scott, Nadine M. Ritterand 1 more
Aug 19, 2022
eBook: Speed to IND — Practical Wisdom for Uncertain Times
Supply Chain
eBook: Speed to IND — Practical Wisdom for Uncertain TimeseBook: Speed to IND — Practical Wisdom for Uncertain Times
byS. Anne Montgomery, John Hilland 5 more
Oct 29, 2021

All from Nadine M. Ritter

Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management
CMC Forums
Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management
Emerging Strategies for Drug-Product Comparability and Process Validation: Part 2 — Validation, Legacy Products, and Lifecycle Management
Apr 16, 2021
+7
byZahra Shahrokh, Andrew Weiskopfand 7 more
Recommendations for Cell Banks Used in GXP Assays logo in a gray background | Recommendations for Cell Banks Used in GXP Assays
Cell Therapies
Recommendations for Cell Banks Used in GXP Assays
Recommendations for Cell Banks Used in GXP Assays
Jan 1, 2012
+3
byAna T. Menendez, Nadine M. Ritterand 3 more
<p> Distinctions Between <i>Analytical</i> and <i>Bioanalytical</i> Test Methods </p> logo in a gray background | <p> Distinctions Between <i>Analytical</i> and <i>Bioanalytical</i> Test Methods </p>
Bioanalytical Methods
Distinctions Between Analytical and Bioanalytical Test Methods
Distinctions Between Analytical and Bioanalytical Test Methods
Mar 1, 2011
byNadine M. Ritter
Stability Considerations for Biopharmaceuticals: Overview of Protein and Peptide Degradation Pathways logo in a gray background | Stability Considerations for Biopharmaceuticals: Overview of Protein and Peptide Degradation Pathways
Formulation
Stability Considerations for Biopharmaceuticals: Overview of Protein and Peptide Degradation Pathways
Stability Considerations for Biopharmaceuticals: Overview of Protein and Peptide Degradation Pathways
Jan 1, 2011
+3
byJalpa Patel, Ruchi Kothariand 3 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe